Dr. Jeff Karp

Leading through Uncertain Times with Dr. Jeff Karp, author of LIT – Life Ignition Tools: Use Nature’s Playbook to Energize Your Brain, Spark Ideas, and Ignite Action

Submitted by on Mon, 04/08/2024 - 11:21
How can government leaders learn, connect, adapt, and draw energy from their experiences? What role does intention play in being a successful leader? How can Life Ignition Tools help leaders be more effective? Join host Michael Keegan on This Special Edition of The Business of Government Hour - Leading Through Uncertain Times with Dr. Jeff Karp, author, LIT - Use Nature’s Playbook to Energize Your Brain, Spark Ideas, and Ignite Action.
Broadcast Date: 
Monday, April 8, 2024 - 11:00
Author: 
Dr. Jeff Karp
Audio: 
Audio icon jeff_karp_podcast_abc.mp3

Dr. Jeff Karp, Researcher-Author

Submitted by on Mon, 04/08/2024 - 11:17
Dr. Jeff Karp is the Distinguished Chair in Anesthesiology at Brigham and Women’s Hospital and Professor of Anesthesia at Harvard Medical School in Boston. He is also a principal faculty member at the Harvard Stem Cell Institute, and an affiliate faculty member at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology.
Distinguished Chair, Anesthesiology, Brigham and Women’s Hospital & Professor of Anesthesia at Harvard Medical School in Bosto
Karp Lab
United States

Dr. Jeff Karp is the Distinguished Chair in Anesthesiology at Brigham and Women’s Hospital and Professor of Anesthesia at Harvard Medical School in Boston. He is also a principal faculty member at the Harvard Stem Cell Institute, and an affiliate faculty member at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology. Karp was elected a fellow of the National Academy of Inventors, Royal Society of Chemistry, American Institute for Medical and Biological Engineering’s College of Fellows, Biomedical Engineering Society (BMES), and the Canadian Academy of Engineering. Jeff runs a basic research laboratory dedicated to the process of medical innovation that harnesses lessons from nature for inspiration (Bioinspiration) from creatures such as geckos spider webs, jellyfish, porcupine quills, snails to spiny headed worms. He works in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives. He has published over 125 peer-reviewed papers, with >32,000 citations, and has given >300 invited lectures. He has >100 issued or pending national and international patents. Several technologies developed in his lab have led to multiple products currently in development or on the market and to the launch of ten companies that have raised over $600 million in funding. Technologies include high-tech skincare (Skintifique, products sold in pharmacies throughout EU), photocurable polymer technology for tissue reconstruction (Tissium, EU Approval in 2017) and 3D printed biomedical devices, immunomodulation with biologically responsive materials (Alivio Tx, acquired by Puretech Health in 2021), small molecule regenerative therapeutics ($FREQ – NASDAQ), cannabinoid therapeutics (Molecular Infusions acquired by Suterra Wellness in 2019), biomedical devices to improve child safety (Landsdowne Labs), needles that automatically stop at their target to deliver gene therapy (Bullseye Therapeutics, acquired by Meira Tx in 2021), a bioengineered luminal coating for controlled GI targeting (Altrix Bio), and a nasal spray to neutralize pathogens (Akita Biosciences).